THE VACCINE GROUP LIMITEDActive

Company number 10842271Private limited companyIncorporated 2017

Key figures

−£686,373-86.3%
Net assets 2024/25
-1 m-500 k0500 k1 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, THE VACCINE GROUP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand257,94878,79227,49971,55051,741
Total assets694,690684,097410,304404,476390,701
Total liabilities337,804129,008401,448772,8901,077,074
Net assets / total equity356,886555,0898,856-368,414-686,373
Average number of employees71111109

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE VACCINE GROUP LIMITED

Company

THE VACCINE GROUP LIMITED is a private limited company registered with Companies House under company number 10842271. It was incorporated on 29 Jun 2017. Its status is active. The registered office is in Cambridge (CB22). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were −£686,373, down 86.3% on the previous year. Cash at bank and in hand was £51,741. Total assets were £390,701 and total liabilities £1,077,074. The company had an average of 9 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 2 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 18 Nov 2026.